DUBLIN, Aug. 20, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that the first patient has been successfully enrolled and received study treatment in its Phase 3 clinical trial ...
First registered, randomized Phase 3 trial evaluating the efficacy, safety, and tolerability of XIAFLEX in adults with hammer toe No FDA-approved nonsurgical therapies currently indicated for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results